Form 5500 · Employee benefit plan · SCOTTSDALE, AZ
TRANSLATIONAL DRUG DEVELOPMENT, LLC
TRANSLATIONAL DRUG DEVELOPMENT, LLC's employee benefit plan is documented in its annual Form 5500 filing with the Department of Labor. Its broker of record is EDBERG PERRY, LLC. Coverage is written through JOHN HANCOCK USA. The plan's most recent policy period ended in December.
Sourced from U.S. DOL EFAST2 Form 5500 · EIN 46-4150915 · plan 001 · as of Jul 2026
Schedule A insurance contracts
| Carrier | Benefits | Covered | Renews | Commission |
|---|---|---|---|---|
| JOHN HANCOCK USA | — | 235 | December | $5,987 |
Questions
Who is TRANSLATIONAL DRUG DEVELOPMENT, LLC's benefits broker?
Per its most recent Form 5500 Schedule A, TRANSLATIONAL DRUG DEVELOPMENT, LLC's broker of record is EDBERG PERRY, LLC.
What insurance carrier does TRANSLATIONAL DRUG DEVELOPMENT, LLC use?
TRANSLATIONAL DRUG DEVELOPMENT, LLC's benefit plan is written through JOHN HANCOCK USA.
When does TRANSLATIONAL DRUG DEVELOPMENT, LLC's group plan renew?
The most recent Schedule A policy period for TRANSLATIONAL DRUG DEVELOPMENT, LLC ended in December. Group plans typically renew on the same annual cycle.
Where does this data come from?
All figures are drawn from TRANSLATIONAL DRUG DEVELOPMENT, LLC's public Form 5500 filing with the U.S. Department of Labor (EFAST2). Form 5500 is a public record.